Immunomedics, Inc.

Pharmaceutical Manufacturing Technologist II

US-NJ-Morris Plains
2 weeks ago
Job ID
2017-1043
# of Openings
3
Category
Scientific Manufacturing/Production

Overview

We are seeking a Pharmaceutical Manufacturing Technologist II to be responsible for the manufacturing of clinical products in compliance with current Good Manufacturing Practice (cGMP) and Standard Operating Procedures (SOPs).

 

Primary schedule will run Monday through Friday alternating between 6:00am-2:30pm and 10:00am-6:30pm, though occasional variation to those hours may be required.  

Responsibilities

  • Operate automated protein purification system for large scale purification of monoclonal antibodies using ion-exchange and affinity column chromatography.
  • Perform virus removal filtration.
  • Prepare buffers (up to 200 L each).
  • Perform integrity tests (filter/membrane).
  • Maintain inventory of raw materials and supplies needed in manufacturing.
  • Daily maintenance and calibration of all equipment needed during production.
  • Monitor and assure adequate supply of glassware/components for manufacturing.
  • Maintain accurate batch records, log books, and log sheets.
  • Write/revise batch records, buffer sheets, SOPs, and Material Safety Sheets (MSSs).

Qualifications

  • Bachelor’s degree in biology, chemistry, or related discipline, plus 1-3 years of industry experience in large scale protein purification, or equivalent combination of education and experience.
  • Proficiency with automated purification software (e.g. UNICORN) is desired.
  • Ability to follow SOPs and cGMP guidelines and regulations.
  • Must possess excellent communication (oral and written) and interpersonal skills. 
  • Detail oriented with strong organizational, follow-through, and problem-solving skills.
  • Must be able to work collaboratively in a team environment. 
  • Must be proficient with MS Office applications. 

 

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed